vcspine

Remiges BioPharma

Remiges BioPharma last closed a fund in June 2014 — 149 months ago.

Next fund
No rhythm to call

1 fund on record — a rhythm needs three. No month is guessed; the filing will say.

No recent fund  This firm has filed no new fund in over five years, so it either stopped raising or raises in a way Form D never sees.

Funds on file
2
Capital raised
$300M
Latest close
June 2014
Based in
MA, NY

Vehicles on file

VehicleFirst closeAmount Filings
Remiges BioPharma Fund, LPJune 2014$150M offered0001609623 ↗
Remiges BioPharma Fund II, LP—$150M offered0001779994 ↗

Each row links to that vehicle’s Form D filings on EDGAR — the name, date and amount above should match what is filed there.

Named on filings

Taro Inaba, Walter Olesiak

What Remiges BioPharma invests in

Typical fund
$150M median, early stage, Series A-B scale
Median of this firm’s filed fund sizes on Form D.
Says it invests in
health/bio
“We invest in and develop technologies and companies that drive innovation in therapeutic development.” — its own site, read September 2026
Website
rdiscovery.com
As filed by the adviser on Form ADV, January 2026.

Sector and stage are quoted from the firm’s own website, not inferred, and dated.

Service providers

Fund administrator
Alter Domus (2 funds)
Auditor
Grant Thornton (2 funds)

From Form ADV filed by REMIGES VENTURES, INC. CRD 175237 ↗, latest filing January 2026, covering 2 funds linked to this firm by Form D file number. Form ADV is filed once a year, so a provider may have changed since. How this is matched.

What this is. Every figure on this page comes from Form D filings with the U.S. Securities and Exchange Commission — public records, reproduced here as filed. Service providers, where shown, come from the adviser’s Form ADV and are dated.

What it is not. Single-deal SPVs, feeder vehicles and GP or employee commitment funds are listed but excluded from fund counts and capital totals: an SPV is one investment, a feeder holds the same capital as its master, and a “Principals” or “Entrepreneurs” fund closes alongside a main fund rather than being raised in its own right. Capital deployed from a family office, a corporate balance sheet or an evergreen structure never arrives as a fund close, so a firm doing that looks quiet here. Amounts are as of the last amendment and go stale. Dates are the date of first sale — a fund's first close, not its final one. Funds filed as “Indefinite” are excluded from totals rather than counted as zero, so a total is a floor.

“No recent fund” is a statement about filings. It is not a statement about whether a firm is solvent, investing, or still in business.